Shanghai Jiaoda Onlly Co.,Ltd (SHA:600530)
6.60
+0.16 (2.48%)
Feb 4, 2026, 3:00 PM CST
SHA:600530 Revenue
Shanghai Jiaoda Onlly Co.,Ltd had revenue of 73.69M CNY in the quarter ending September 30, 2025, a decrease of -4.16%. This brings the company's revenue in the last twelve months to 312.75M, up 10.66% year-over-year. In the year 2024, Shanghai Jiaoda Onlly Co.,Ltd had annual revenue of 325.18M with 9.74% growth.
Revenue (ttm)
312.75M
Revenue Growth
+10.66%
P/S Ratio
15.96
Revenue / Employee
342.92K
Employees
912
Market Cap
4.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 325.18M | 28.85M | 9.74% |
| Dec 31, 2023 | 296.33M | -80.82M | -21.43% |
| Dec 31, 2022 | 377.15M | 14.57M | 4.02% |
| Dec 31, 2021 | 362.58M | 29.88M | 8.98% |
| Dec 31, 2020 | 332.70M | 92.83K | 0.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ZhuZhou QianJin Pharmaceutical Co.,Ltd | 3.63B |
| Jianmin Pharmaceutical Group | 3.18B |
| Luoxin Pharmaceuticals Group Stock | 2.49B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.74B |
| Fuan Pharmaceutical (Group) | 1.71B |
| Hunan Fangsheng Pharmaceutical | 1.68B |
| Bide Pharmatech | 1.27B |
| Zhuhai Rundu Pharmaceutical | 1.19B |